Abstract:Background: Apoptosis is an important cellular pathological process in D-galactosamine (D-GalN)/lipopolysaccharide (LPS)-stimulated liver injury. Long noncoding RNAs (lncRNA) are involved in liver injury, but their mechanisms of action in fulminant hepatic failure (FHF) remain unclear. The aim of this study is to investigate the effect of NEAT1, an lncRNA, on apoptosis and proliferation of hepatocytes.Methods: Initially, we collected FHF clinical samples and established an in vitro cell model and an in vivo rat model of FHF by using (D-GalN)/LPS. The expression pattern of NEAT1 and LATS2 were then determined by RT-PCR and ELISA assay. Following the verification of the binding relationship between NEAT1, EZH2 and LATS2, gain-of- and loss-of-function experiments were applied to analyze the effects of NEAT1, EZH2 and LATS2 on hepatocyte proliferation and apoptosis, determined by EdU and Tunnel assay respectively. In addition, involvement of Hippo-YAP pathway was explored.Results: NEAT1 was highly expressed in FHF tissues, FHF cells and FHF rat model, in contrast LATS2 was downregulated. LATS2 was negatively correlated with NEAT1. After D-GalN/LPS treatment, NEAT1 inhibited the expression of LATS2 and cell proliferation, but promoted apoptosis. Furthermore, mechanistic investigation indicated that NEAT1 recruited EZH2 to LAST2 promoter region and mediate the methylation of H3K27me3, ultimately activate the Hippo-YAP axis. Besides, down-regulation of NEAT1 or overexpression of LAST2 inhibits liver injury caused by FHF in vivo.Conclusion: The NEAT1 modulate hepatocyte apoptosis in fulminant hepatic failure by recruiting EZH2 to LATS2 promoter region and promotes H3K27me3 methylation, highlighting new therapeutic directions in FHF.Funding: This study was supported by Hunan Provincial Natural Science Foundation Youth Fund Project (No. 2017JJ3427).Declaration of Interest: The authors declare that they have no competing interests.Ethical Approval: The study was approved by the ethics committee of the Third Xiangya Hospital of Central South University and the informed consents were singed by all participants or their guardians. The animal experiments are strictly designed and carried out according to the Guide for the Care and Use of Laboratory Animal by International Committees. Great efforts were made to minimize the number of animals used in the experiments and their suffering.

LncRNA NEAT1 : Shedding light on mechanisms and opportunities in liver diseases

LncRNA NEAT1 in the pathogenesis of liver‐related diseases

Long Non-coding RNA NEAT1 Alleviates Acute-on-Chronic Liver Failure Through Blocking TRAF6 Mediated Inflammatory Response

LncRNA NEAT1 Promotes Deterioration of Hepatocellular Carcinoma Based on In Vitro Experiments, Data Mining, and RT-qPCR Analysis.

LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review

Long noncoding RNA NEAT1 suppresses hepatocyte proliferation in fulminant hepatic failure through increased recruitment of EZH2 to the LATS2 promoter region and promotion of H3K27me3 methylation

Long Non-Coding RNA NEAT1 Inhibits Hepatocyte Proliferation in Fulminant Hepatic Failure Through H3K27me3 Methylation-Dependent Promotion of LATS2

Long Non-Coding Rna Profiling In A Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight Into Pathogenesis

lncRNA NEAT1: key player in neurodegenerative diseases

NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6

LncRNA NEAT1 Regulates Proliferation, Apoptosis and Invasion of Liver Cancer.

Silencing Long Noncoding RNA NEAT1 Alleviates Acute Liver Failure Via the EZH2-mediated Microrna-139/Puma Axis

The Lncrna NEAT1 Inhibits Mirna-216B and Promotes Colorectal Cancer Progression by Indirectly Activating YY1

Long Non-Coding RNA NEAT1-modulated Abnormal Lipolysis Via ATGL Drives Hepatocellular Carcinoma Proliferation.

Retraction Note: Upregulation of Long Noncoding RNA ZEB1-AS1 Promotes Tumor Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma

Pan-cancer analysis of long non-coding RNA NEAT1 in various cancers

Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness

Long Non-Coding RNA NEAT1 Overexpression is Associated with Poor Prognosis in Cancer Patients: a Systematic Review and Meta-Analysis

LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease

Down‐regulation of lncRNA‐NEAT1 alleviated the non‐alcoholic fatty liver disease via mTOR/S6K1 signaling pathway

NEAT1 As a Competing Endogenous RNA in Tumorigenesis of Various Cancers: Role, Mechanism and Therapeutic Potential